Philippines FDA (FDA PH) โ Center for Device Regulation, Radiation Health and Research (CDRRHR)
Medical devices in the Philippines are regulated by the Food and Drug Administration Philippines (FDA PH) under Republic Act 9711 (Food and Drug Administration Act of 2009). The Center for Device Regulation, Radiation Health and Research (CDRRHR) within FDA PH handles medical device registration. All medical devices must obtain a Certificate of Product Registration (CPR) before commercial sale.
FDA PH classifies medical devices into four classes (Class AโD) aligned with the ASEAN Medical Device Directive (AMDD). Class A (lowest risk) requires notification; Class BโD require full CPR application with supporting technical documentation. Foreign manufacturers must appoint a Philippine-based local representative (LR) or authorized representative to file applications on their behalf.
The Philippines is a member of the ASEAN Medical Device Committee (AMDC) and is moving toward ASEAN harmonization. Devices with approved CE, FDA, or ASEAN reference country approvals may qualify for simplified review pathways, and the ASEAN Common Submission Dossier Template (CSDT) is progressively being adopted.
- All devices require a Certificate of Product Registration (CPR) before commercial supply
- Philippine-based Local Representative required โ foreign manufacturers cannot apply directly
- ASEAN CSDT format increasingly accepted for technical dossier submission
- Post-market obligations: adverse event reporting, recall management, CPR renewal (every 5 years)
- License to Operate (LTO) required for all importers and distributors
FDA PH CPR Timelines by Device Class
Target review times from application submission โ LTO procurement for local representative runs in parallel.
Integrated Services for Philippines FDA PH Registration
FDA PH CPR Registration
End-to-end Certificate of Product Registration (CPR) management โ CDRRHR dossier preparation, CSDT format compliance, application filing, query response, and CPR maintenance and renewal. Class AโD registration and IVD registration included.
Local Representative (LR)
JNPMEDI APAC coordinates appointment of a Philippines-based Local Representative for FDA PH submissions. Covers LTO application, authorized representative agreement, and ongoing compliance including adverse event reporting and CPR renewal management.
ASEAN Simultaneous Filing
Philippines CSDT dossiers are compatible with ASEAN harmonized submissions across Malaysia, Indonesia, Vietnam, Thailand, and Singapore. JNPMEDI APAC coordinates simultaneous ASEAN filings to maximize document reuse and reduce total ASEAN registration cost.
Why JNPMEDI APAC for Philippines FDA PH Registration
The Philippines is adopting the ASEAN Common Submission Dossier Template (CSDT) โ the same format used across Malaysia, Indonesia, Vietnam, and Thailand. JNPMEDI APAC prepares CSDT-format dossiers that can be reused with minor adaptation across all ASEAN markets, dramatically reducing total regional registration cost.
The Philippines is one of Southeast Asia's most dynamic markets โ 115M population, 6%+ GDP growth, a rapidly expanding middle class, and heavy public investment in Universal Health Coverage (UHC). For medical device manufacturers, it represents a significant long-term volume market despite shorter-term regulatory complexity.
JNPMEDI APAC operates across all ASEAN markets. Philippines registration is coordinated alongside Singapore, Malaysia, Indonesia, Vietnam, and Thailand โ enabling a single-vendor ASEAN regulatory program with shared dossier management, reducing vendor overhead and improving regulatory consistency across all six markets.
Philippines FDA PH Registration โ FAQ
Yes. FDA PH requires a Philippines-based Local Representative (LR) or Authorized Representative to submit CPR applications and hold registrations on behalf of foreign manufacturers. The LR must also hold a valid License to Operate (LTO) issued by FDA PH. JNPMEDI APAC coordinates LR appointment and LTO acquisition as part of our Philippines registration service.
The ASEAN Common Submission Dossier Template (CSDT) is a harmonized technical dossier format adopted by ASEAN member states to standardize medical device registration requirements. The Philippines is progressively adopting CSDT under the ASEAN Medical Device Directive (AMDD) framework. JNPMEDI APAC prepares CSDT-compliant dossiers that are accepted by FDA PH and reusable across other ASEAN markets with minimal adaptation.
A Certificate of Product Registration (CPR) issued by FDA PH is typically valid for five years from the date of issuance. Renewal applications must be submitted before expiry to maintain continuous market authorization. JNPMEDI APAC manages CPR renewal timelines and renewal submissions as part of our ongoing Philippines market maintenance service.
Yes. JNPMEDI APAC coordinates simultaneous ASEAN submissions across the Philippines, Singapore, Malaysia, Indonesia, Vietnam, and Thailand under a single engagement. CSDT dossier components are shared across all six markets, and our regional RA team manages timeline coordination, query responses, and approval tracking across all jurisdictions simultaneously.